PRESS RELEASE : Ypso-Facto is part of the CALIPSO project led by Sanofi, to disrupt the production of biomedicines!
Supported by Bpifrance, the CALIPSO project aims at developing a new generation of tools that will disrupt industrial bioproduction processes.
Nancy, France, 16 Sept 2021 - Ypso-Facto is proud to play a major role in this challenging and exciting project. With its expertise in bioprocesses and predictive simulation, Ypso-Facto will develop software solutions to support production of innovative therapies.
The company will work on three software tools that will allow:
- to visualize and analyse research and production data in order to extract meaningful information for rational decision-making;
- the predictive simulation of fermentation and cell culture bioreactors;
- the predictive simulation of affinity chromatography, ion exchange or hydrophobic interaction purification systems.
These software tools will help accelerating process development time, improving productivity and minimizing environmental impact. Ypso-Facto is committed to support the bioproduction sector to deliver constantly improving processes.
For more information, download the pdf below or contact us : contact@ypso-facto.com
Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.